bluebird bio
BLUE
#9803
Rank
$48.66 M
Marketcap
$4.97
Share price
0.00%
Change (1 day)
-75.64%
Change (1 year)

Revenue for bluebird bio (BLUE)

Revenue in 2025 (TTM): $0.10 Billion USD

According to bluebird bio 's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2024 the company made a revenue of $83.8 Million USD an increase over the revenue in the year 2023 that were of $29.49 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for bluebird bio from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.10 B24.03%
2024 $83.8 M184.12%
2023 $29.49 M719.82%
2022 $3.59 M-109.67%
2021 -$37.23 Million-114.85%
2020 $0.25 B461.25%
2019 $44.67 M-18.15%
2018 $54.57 M54.06%
2017 $35.42 M475.58%
2016 $6.15 M-56.29%
2015 $14.08 M-44.61%
2014 $25.42 M25.97%
2013 $20.18 M5835.59%
2012 $0.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
BioMarin Pharmaceutical
BMRN
$3.09 B 2,876.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
$0.11 B 8.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$47.52 B 45,620.93%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
$32.87 M-68.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$64.23 B 61,696.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA